Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

Trillium Therapeutics Inc

Website:
trilliumtherapeutics.com
Headquarters:
Toronto, ON, CA
Company Type:
Small Business (1-10M TTM Revenue)

Trillium Therapeutics Inc. (TTI) is a privately-owned biopharmaceutical company with two main areas of focus: cytoprotection and immune regulation. The Company’s cytoprotection programs are based upon a recombinant form of heparin-binding epidermal growth factor-like growth factor (HB-EGF).

Site Badges
Trillium Therapeutics Inc
96 Skyway Avenue Toronto, ON, M9W 4Y9 Canada

Get started

If your organization has a Scientist.com marketplace, you can log in here to order products and services directly.

If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here.

To order products instantly, request access below.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service